Another two value stocks are:
RPXC 9.40 and 3.00 cash per share, patent risk management solutions in the US, Japan, Korea, internationally.
SLP 7.36 and 0.00 debt, drug discovery and development software for mechanistic modeling and simulation
There is an activist investor, the company has hired and investment advisor (possible sale), no debt, great balance sheet. Easy target for buyout. The company is just small and no one pays attention to it. Someone will. If you actually do research on this company and don't decide to invest in it, then you don't know how to invest.